Laboratory response to paradigm change in hemophilia treatment

Clin Chem Lab Med. 2023 Jun 15;61(12):e248-e250. doi: 10.1515/cclm-2023-0443. Print 2023 Nov 27.

Marjan Shafaati Lambert^{1

2}, Maria Bruzelius^{3

4}, Nida Mahmoud Hourani Soutari^{1

2}, Susanna Ranta^{5

6}, Jovan P Antovic^{1

2}

¹ Coagulation & Clinical Chemistry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
² Coagulation, Clinical Chemistry, Karolinska University Laboratory, Medical Diagnostics Karolinska, Karolinska University Hospital, Stockholm, Sweden.
³ Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
⁵ Astrid Lindgren's Children's Hospital, Karolinska Univeristy Hospital, Stockholm, Sweden.
⁶ Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Keywords: FVIII concentrate; FVIII:C CSA; emicizumab.

Publication types